Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leuprolide and Testosterone for Men With Kennedy's Disease or Other Motor Neuron Disease
NCT00004771Phase 2Completed
- Sponsor
- National Center for Research Resources
- Start
- Oct 1992
- Modality
- Peptides, Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of leuprolide and testosterone in spinal and bulbar muscular atrophy (SBMA), amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA), sponsored by National Center for Research Resources. Started Oct 1992; status: completed.
02
Drugs
leuprolidetestosterone
03
Conditions
spinal and bulbar muscular atrophy (SBMA)amyotrophic lateral sclerosis (ALS)spinal muscular atrophy (SMA)
Beyond the preview
Go deeper on NCT00004771.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004771.